Clarius Group LLC’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$552K Sell
1,418
-954
-40% -$371K 0.03% 232
2025
Q1
$1.03M Buy
2,372
+558
+31% +$243K 0.06% 137
2024
Q4
$669K Sell
1,814
-9
-0.5% -$3.32K 0.05% 171
2024
Q3
$948K Sell
1,823
-56
-3% -$29.1K 0.07% 130
2024
Q2
$1.02M Sell
1,879
-60
-3% -$32.5K 0.07% 115
2024
Q1
$1.01M Sell
1,939
-278
-13% -$144K 0.07% 118
2023
Q4
$1.05M Sell
2,217
-21
-0.9% -$9.9K 0.09% 119
2023
Q3
$974K Sell
2,238
-656
-23% -$286K 0.09% 119
2023
Q2
$1.29M Buy
2,894
+62
+2% +$27.5K 0.1% 109
2023
Q1
$1.3M Sell
2,832
-47
-2% -$21.6K 0.11% 107
2022
Q4
$1.48M Buy
2,879
+73
+3% +$37.5K 0.13% 93
2022
Q3
$1.28M Buy
2,806
+60
+2% +$27.3K 0.13% 95
2022
Q2
$1.33M Buy
2,746
+159
+6% +$76.7K 0.13% 101
2022
Q1
$1.2M Hold
2,587
0.09% 114
2021
Q4
$1.2M Buy
2,587
+15
+0.6% +$6.95K 0.09% 114
2021
Q3
$959K Buy
2,572
+78
+3% +$29.1K 0.09% 126
2021
Q2
$952K Sell
2,494
-18
-0.7% -$6.87K 0.09% 125
2021
Q1
$902K Buy
2,512
+409
+19% +$147K 0.09% 121
2020
Q4
$675K Buy
2,103
+74
+4% +$23.8K 0.07% 134
2020
Q3
$545K Sell
2,029
-274
-12% -$73.6K 0.07% 127
2020
Q2
$606K Buy
2,303
+270
+13% +$71K 0.08% 116
2020
Q1
$462K Buy
2,033
+304
+18% +$69.1K 0.09% 115
2019
Q4
$521K Sell
1,729
-25
-1% -$7.53K 0.08% 122
2019
Q3
$421K Buy
1,754
+606
+53% +$145K 0.08% 141
2019
Q2
$324K Sell
1,148
-40
-3% -$11.3K 0.07% 156
2019
Q1
$341K Buy
+1,188
New +$341K 0.08% 127
2018
Q3
Sell
-1,046
Closed -$249K 127
2018
Q2
$249K Buy
+1,046
New +$249K 0.1% 71